Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12051-12068

  Orav, Marit ^a   Henno, Liisi ^a   Isok Paas, Helen ^a   Geimanen, Jelizaveta ^a   Ustav, Mart ^a,c,d   Ustav, Ene ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c Icosagen Cell Factory OU   (Estonia)

^d ESTONIAN ACADEMY OF SCIENCES   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLYCOPROTEIN E1; GLYCOPROTEIN E2; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN C 33; CELL STRAIN SIHA; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPLICATION; GENETIC TRANSFECTION; HELA CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS GENOME; VIRUS REPLICATION; BONE TUMOR; FEMALE; GENETIC RECOMBINATION; GENETICS; METABOLISM; OSTEOSARCOMA; PAPILLOMA; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; SOUTHERN BLOTTING; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

BLOTTING, SOUTHERN; BONE NEOPLASMS; DNA REPLICATION; DNA, VIRAL; FEMALE; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 18; HUMANS; OSTEOSARCOMA; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; RECOMBINATION, GENETIC; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84886257633     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01798-13     Document Type: Article

References (78)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
2. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
4. Gillison ML, Lowy DR. 2004. A causal role for human papillomavirus in head and neck cancer. Lancet 363:1488-1489.
5. Kadaja M, Silla T, Ustav E, Ustav M. 2009. Papillomavirus DNA replication-from initiation to genomic instability. Virology 384:360-368.
6. Schuck S, Stenlund A. 2005. Assembly of a double hexameric helicase. Mol. Cell 20:377-389.
7. Sedman J, Stenlund A. 1998. The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol. 72:6893-6897.
8. Ustav M, Stenlund A. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457.
9. Yang L, Mohr I, Fouts E, Lim DA, Nohaile M, Botchan M. 1993. The E1-protein of bovine papilloma virus-1 is an ATP-dependent DNA helicase. Proc. Natl. Acad. Sci. U. S. A. 90:5086-5090.
10. Remm M, Brain R, Jenkins JR. 1992. The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res. 20:6015-6021.
11. Chiang CM, Ustav M, Stenlund A, Ho TF, Broker TR, Chow LT. 1992. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. U. S. A. 89:5799-5803.
12. Enemark EJ, Stenlund A, Joshua-Tor L. 2002. Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. EMBO J. 21:1487-1496.
13. Enemark EJ, Chen G, Vaughn DE, Stenlund A, Joshua-Tor L. 2000. Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol. Cell 6:149-158.
14. Sedman T, Sedman J, Stenlund A. 1997. Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J. Virol. 71:2887-2896.
15. Sedman J, Stenlund A. 1995. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J. 14:6218-6228.
16. Flores ER, Lambert PF. 1997. Evidence for a switch in the mode of human papillomavirus type 16DNAreplication during the viral life cycle. J. Virol. 71:7167-7179.
17. Dasgupta S, Zabielski J, Simonsson M, Burnett S. 1992. Rolling-circle replication of a high-copy BPV-1 plasmid. J. Mol. Biol. 228:1-6.
18. Reinson T, Toots M, Kadaja M, Pipitch R, Allik M, Ustav E, Ustav M. 2013. Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J. Virol. 87:951-964.
19. Sakakibara N, Mitra R, McBride AA. 2011. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 85:8981-8995.
20. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. 2009. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 5:e1000397. doi:10.1371/journal.ppat.1000397.
21. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, Archambault J. 2011. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATMdependent DNA damage response. J. Virol. 85:8996-9012.
22. Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 5:e1000605. doi:10.1371/journal.ppat.1000605.
23. Gillespie KA, Mehta KP, Laimins LA, Moody CA. 2012. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J. Virol. 86:9520-9526.
24. Geimanen J, Isok-Paas H, Pipitch R, Salk K, Laos T, Orav M, Reinson T, Ustav M, Jr, Ustav M, Ustav E. 2011. Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J. Virol. 85:3315-3329.
25. Barbosa MS, Vass WC, Lowy DR, Schiller JT. 1991. In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J. Virol. 65:292-298.
26. Thomas JT, Oh ST, Terhune SS, Laimins LA. 2001. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J. Virol. 75:7564-7571.
27. Kristiansen E, Jenkins A, Holm R. 1994. Coexistence of episomal and integrated HPV16 DNA in squamous-cell carcinoma of the cervix. J. Clin. Pathol. 47:253-256.
28. Durst M, Kleinheinz A, Hotz M, Gissmann L. 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol. 66(Part 7):1515-1522.
29. Cullen AP, Reid R, Campion M, Lorincz AT. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
30. Choo KB, Cheung WF, Liew LN, Lee HH, Han SH. 1989. Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J. Virol. 63:782-789.
31. Adachi A, Kiyono T, Hayashi Y, Ohashi M, Ishibashi M. 1996. Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs. J. Clin. Microbiol. 34:369-375.
32. Choo KB, Pan CC, Liu MS, Ng HT, Chen CP, Lee YN, Chao CF, Meng CL, Yeh MY, Han SH. 1987. Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J. Med. Virol. 21: 101-107.
33. Hubert WG, Kanaya T, Laimins LA. 1999. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that Lie 5 = of the minimal origin. J. Virol. 73:1835-1845.
34. Frattini MG, Lim HB, Doorbar J, Laimins LA. 1997. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71:7068-7072.
35. Thomas JT, Hubert WG, Ruesch MN, Laimins LA. 1999. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 96:8449-8454.
36. Bodily JM, Mehta KPM, Cruz L, Meyers C, Laimins LA. 2011. The E7 open reading frame acts in cis and in trans to mediate differentiationdependent activities in the human papillomavirus type 16 life cycle. J. Virol. 85:8852-8862.
37. Kay MA, He CY, Chen ZY. 2010. A robust system for production of minicircle DNA vectors. Nat. Biotechnol. 28:1287-1289.
38. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM. 2011. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J. Virol. 85:8080-8092.
39. Chen ZY, He CY, Kay MA. 2005. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum. Gene Ther. 16:126-131.
40. Kurg R, Uusen P, Vosa L, Ustav M. 2010. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 408:159-166.
41. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M. 2007. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J. 26:2180-2191.
42. Hirt B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
43. Ustav M, Ustav E, Szymanski P, Stenlund A. 1991. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10:4321-4329.
44. Liu LF, Depew RE, Wang JC. 1976. Knotted single-stranded DNA rings: a novel topological isomer of circular single-stranded DNA formed by treatment with Escherichia coli omega protein. J. Mol. Biol. 106:439-452.
45. Kirkegaard K, Wang JC. 1978. Escherichia coli DNA topoisomerase I catalyzed linking of single-stranded rings of complementary base sequences. Nucleic Acids Res. 5:3811-3820.
46. Martin-Parras L, Lucas I, Martinez-Robles ML, Hernandez P, Krimer DB, Hyrien O, Schvartzman JB. 1998. Topological complexity of different populations of pBR322 as visualized by two-dimensional agarose gel electrophoresis. Nucleic Acids Res. 26:3424-3432.
47. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, Lowy DR, Schiller JT. 1993. Efficient self-assembly of human papillomavirus type-16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
48. Ustav E, Ustav M, Szymanski P, Stenlund A. 1993. The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Natl. Acad. Sci. U. S. A. 90:898-902.
49. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. 1989. HPV16 E6-proteins and E7-proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
50. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
51. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. 1989. Complex-formation of human papillomavirus-E7 proteins with the retinoblastoma tumor suppressor gene-product. EMBO J. 8:4099-4105.
52. Boyer SN, Wazer DE, Band V. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620-4624.
53. McLaughlin-Drubin ME, Munger K. 2009. The human papillomavirus E7 oncoprotein. Virology 384:335-344.
54. Howie HL, Katzenellenbogen RA, Galloway DA. 2009. Papillomavirus E6 proteins. Virology 384:324-334.
55. Pim D, Banks L. 2010. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS 118:471-493.
56. Roberts S, Ashmole I, Johnson GD, Kreider JW, Gallimore PH. 1993. Cutaneous and mucosal human papillomavirus-E4 proteins form intermediate filament-like structures in epithelial cells. Virology 197:176-187.
57. Doorbar J, Ely S, Sterling J, Mclean C, Crawford L. 1991. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial-cell intermediate filament network. Nature 352:824-827.
58. Davy CE, Jackson DJ, Wang Q, Raj K, Masterson PJ, Fenner NF, Southern S, Cuthill S, Millar JBA, Doorbar J. 2002. Identification of a G(2) arrest domain in the E1 Boolean AND E4 protein of human papillomavirus type 16. J. Virol. 76:9806-9818.
59. Conrad M, Bubb VJ, Schlegel R. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
60. Hwang ES, Nottoli T, Dimaio D. 1995. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211:227-233.
61. Oelze I, Kartenbeck J, Crusius K, Alonso A. 1995. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69:4489-4494.
62. Fehrmann F, Klumpp DJ, Laimins LA. 2003. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77:2819-2831.
63. Stracker TH, Carson CT, Weitzman MD. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
64. Hong S, Laimins LA. 2013. The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog. 9:e1003295. doi:10.1371/journal.ppat.1003295.
65. Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA, Coleman N. 2002. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 62:6959-6965.
66. De Geest K, Turyk ME, Hosken MI, Hudson JB, Laimins LA, Wilbanks GD. 1993. Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol. Oncol. 49:303-310.
67. Stanley MA, Browne HM, Appleby M, Minson AC. 1989. Properties of a nontumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43:672-676.
68. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
69. Schneider-Gadicke A, Schwarz E. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
70. Friedl F, Kimura I, Osato T, Ito Y. 1970. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc. Soc. Exp. Biol. Med. 135:543-545.
71. Scherer WF, Syverton JT, Gey GO. 1953. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J. Exp. Med. 97:695-710.
72. Auersperg N. 1964. Long-term cultivation of hypodiploid human tumor cells. J. Natl. Cancer Inst. 32:135-163.
73. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:361-366.
74. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, Hausen H. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3:1151-1157.
75. Pater MM, Pater A. 1985. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 145:313-318.
76. Li X, Heyer WD. 2008. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 18:99-113.
77. Krysan PJ, Haase SB, Calos MP. 1989. Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9:1026-1033.
78. Schvartzman JB, Adolph S, Martinparras L, Schildkraut CL. 1990. Evidence that replication initiates at only some of the potential origins in each oligomeric form of bovine papillomavirus type-1 DNA. Mol. Cell. Biol. 10:3078-3086.